283 related articles for article (PubMed ID: 30660327)
1. Incontinentia Pigmenti.
Cammarata-Scalisi F; Fusco F; Ursini MV
Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):273-278. PubMed ID: 30660327
[TBL] [Abstract][Full Text] [Related]
2. [Incontinentia pigmenti (Bloch-Sulzberger syndrome)].
Mühlenstädt E; Eigelshoven S; Hoff NP; Reifenberger J; Homey B; Bruch-Gerharz D
Hautarzt; 2010 Oct; 61(10):831-3. PubMed ID: 20865235
[TBL] [Abstract][Full Text] [Related]
3. Incontinentia Pigmenti: A Summary Review of This Rare Ectodermal Dysplasia With Neurologic Manifestations, Including Treatment Protocols.
Greene-Roethke C
J Pediatr Health Care; 2017; 31(6):e45-e52. PubMed ID: 28870493
[TBL] [Abstract][Full Text] [Related]
4. NEMO gene mutations in Chinese patients with incontinentia pigmenti.
Hsiao PF; Lin SP; Chiang SS; Wu YH; Chen HC; Lin YC
J Formos Med Assoc; 2010 Mar; 109(3):192-200. PubMed ID: 20434027
[TBL] [Abstract][Full Text] [Related]
5. Incontinentia Pigmenti: X-Linked Skin Disorder: A Case Report.
Gelardi L
Neonatal Netw; 2022 Mar; 41(2):89-93. PubMed ID: 35260425
[TBL] [Abstract][Full Text] [Related]
6. [Two neonates with vesicular skin lesions due to incontinentia pigmenti].
Winterberg DH; van Tijn DA; Smitt JH; Winterberg S; Vomberg PP
Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2178-82. PubMed ID: 11727618
[TBL] [Abstract][Full Text] [Related]
7. Incontinentia pigmenti (Bloch-Sulzberger syndrome).
Narayanan MJ; Rangasamy S; Narayanan V
Handb Clin Neurol; 2015; 132():271-80. PubMed ID: 26564087
[TBL] [Abstract][Full Text] [Related]
8. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.
Berlin AL; Paller AS; Chan LS
J Am Acad Dermatol; 2002 Aug; 47(2):169-87; quiz 188-90. PubMed ID: 12140463
[TBL] [Abstract][Full Text] [Related]
9. [Variable clinical expression of familial Incontinentia Pigmenti syndrome - presentation of three cases].
Kutkowska-Kaźmierczak A; Obersztyn E; Bonnefont JP; Rosińska-Borkowska D; Mazurczak T; Sobczyńska-Tomaszewska A; Mazurczak T
Med Wieku Rozwoj; 2008; 12(3):748-53. PubMed ID: 19305025
[TBL] [Abstract][Full Text] [Related]
10. The common NF-κB essential modulator (NEMO) gene rearrangement in Korean patients with incontinentia pigmenti.
Song MJ; Chae JH; Park EA; Ki CS
J Korean Med Sci; 2010 Oct; 25(10):1513-7. PubMed ID: 20890435
[TBL] [Abstract][Full Text] [Related]
11. An atypical case of incontinentia pigmenti with a hypomorphic variant.
Guo Y; Bu W; Jia W; Zhang Y; Li C
Pediatr Dermatol; 2024; 41(2):351-353. PubMed ID: 37853991
[TBL] [Abstract][Full Text] [Related]
12. Abnormal white matter in a neurologically intact child with incontinentia pigmenti.
Bryant SA; Rutledge SL
Pediatr Neurol; 2007 Mar; 36(3):199-201. PubMed ID: 17352958
[TBL] [Abstract][Full Text] [Related]
13. Incontinentia pigmenti (Bloch-Sulzberger syndrome): a systemic disorder.
Ehrenreich M; Tarlow MM; Godlewska-Janusz E; Schwartz RA
Cutis; 2007 May; 79(5):355-62. PubMed ID: 17569396
[TBL] [Abstract][Full Text] [Related]
14. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome.
Kenwrick S; Woffendin H; Jakins T; Shuttleworth SG; Mayer E; Greenhalgh L; Whittaker J; Rugolotto S; Bardaro T; Esposito T; D'Urso M; Soli F; Turco A; Smahi A; Hamel-Teillac D; Lyonnet S; Bonnefont JP; Munnich A; Aradhya S; Kashork CD; Shaffer LG; Nelson DL; Levy M; Lewis RA;
Am J Hum Genet; 2001 Dec; 69(6):1210-7. PubMed ID: 11673821
[TBL] [Abstract][Full Text] [Related]
15. Insight into IKBKG/NEMO locus: report of new mutations and complex genomic rearrangements leading to incontinentia pigmenti disease.
Conte MI; Pescatore A; Paciolla M; Esposito E; Miano MG; Lioi MB; McAleer MA; Giardino G; Pignata C; Irvine AD; Scheuerle AE; Royer G; Hadj-Rabia S; Bodemer C; Bonnefont JP; Munnich A; Smahi A; Steffann J; Fusco F; Ursini MV
Hum Mutat; 2014 Feb; 35(2):165-77. PubMed ID: 24339369
[TBL] [Abstract][Full Text] [Related]
16. Incontinentia pigmenti / Bloch-Sulzberger syndrome: a case report.
Nirmalasari DA; Tabri F; Waspodo N; Rimayani S; Adriani A
Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(1):39-41. PubMed ID: 35339131
[TBL] [Abstract][Full Text] [Related]
17. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.
Smahi A; Courtois G; Vabres P; Yamaoka S; Heuertz S; Munnich A; Israël A; Heiss NS; Klauck SM; Kioschis P; Wiemann S; Poustka A; Esposito T; Bardaro T; Gianfrancesco F; Ciccodicola A; D'Urso M; Woffendin H; Jakins T; Donnai D; Stewart H; Kenwrick SJ; Aradhya S; Yamagata T; Levy M; Lewis RA; Nelson DL
Nature; 2000 May; 405(6785):466-72. PubMed ID: 10839543
[TBL] [Abstract][Full Text] [Related]
18. Genomic architecture at the Incontinentia Pigmenti locus favours de novo pathological alleles through different mechanisms.
Fusco F; Paciolla M; Napolitano F; Pescatore A; D'Addario I; Bal E; Lioi MB; Smahi A; Miano MG; Ursini MV
Hum Mol Genet; 2012 Mar; 21(6):1260-71. PubMed ID: 22121116
[TBL] [Abstract][Full Text] [Related]
19. Incontinentia pigmenti in a male (XY) infant with long-term follow up over 8 years.
Matsuzaki Y; Rokunohe A; Minakawa S; Nomura K; Nakano H; Ito E; Sawamura D
J Dermatol; 2018 Jan; 45(1):100-103. PubMed ID: 28791733
[TBL] [Abstract][Full Text] [Related]
20. Incontinentia pigmenti in a newborn with NEMO mutation.
Lee Y; Kim S; Kim K; Chang M
J Korean Med Sci; 2011 Feb; 26(2):308-11. PubMed ID: 21286028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]